Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRI
NCT06833775 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2025-02-20
Summary
This study aims to predict the efficacy of different types of neoadjuvant therapy and related postoperative pathological indicators in patients with esophageal cancer based on imaging parameters from CT and multimodal MRI, as well as clinical indicators collected before and after neoadjuvant treatment.
Conditions
- Esophageal Cancer
- Neoadjuvant Therapy
Sponsors & Collaborators
-
Henan Cancer Hospital
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-31
- Primary Completion
- 2030-01-31
- Completion
- 2030-12-31
More Related Trials
-
Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT06888531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer
NCT02938195 ·Status: UNKNOWN ·Phase: PHASE2
-
Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer
NCT02972372 ·Status: RECRUITING ·Phase: NA
-
MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma
NCT06640153 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
NCT01745107 ·Status: UNKNOWN ·Phase: PHASE3
-
Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer
NCT06385717 ·Status: RECRUITING
-
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer
NCT03120572 ·Status: COMPLETED
-
Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer
NCT03474341 ·Status: UNKNOWN
-
Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
NCT06602843 ·Status: RECRUITING ·Phase: NA
-
Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
NCT05894369 ·Status: RECRUITING
-
MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy
NCT02988921 ·Status: RECRUITING ·Phase: NA
-
Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer
NCT04688801 ·Status: RECRUITING ·Phase: NA
-
Detection of (Sub)Clinical Toxicity in Irradiated vs. Non-irradiated Surgically Treated Esophageal Cancer Patients: a Pilot Study (CROSS SECT)
NCT03396614 ·Status: COMPLETED
-
A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer
NCT03708042 ·Status: UNKNOWN ·Phase: PHASE3
-
Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and Digital Pathology
NCT07203690 ·Status: NOT_YET_RECRUITING
-
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma
NCT04275986 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer
NCT02959385 ·Status: UNKNOWN ·Phase: PHASE2
-
Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer
NCT04014465 ·Status: UNKNOWN
-
Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach
NCT02448979 ·Status: UNKNOWN ·Phase: PHASE3
-
Neoadjuvant Treatment Modalities in Esophageal Cancer
NCT04821843 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer
NCT03286920 ·Status: UNKNOWN
-
Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer
NCT01463501 ·Status: UNKNOWN ·Phase: PHASE2
-
Adaptive Neoadjuvant Therapy for Esophageal Cancer
NCT06990178 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Chemoradiotherapy Plus Immunotherapy Followed by Surgery for Esophageal Cancer
NCT04776590 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Multimodal Endoscopic Image Fusion for Assessing Infiltration in Superficial Esophageal Squamous Cell Carcinoma
NCT06412419 ·Status: NOT_YET_RECRUITING